EPISODE · Jul 15, 2026 · 4 MIN
Estée Lauder Keeps Three, Bluemercury's New CEO
from Beauty in Five
Estée Lauder to Retain Too Faced, Smashbox, Dr. Jart+. WWD reports the three brands are no longer on the block, a signal of how Estée Lauder is weighing divestiture against turnaround. (WWD Beauty) Bluemercury Names Alex Choueiri Chief Executive Officer. The Macy's-owned beauty retailer hands its top job to a prestige-brand operator, per WWD, as it competes with Sephora and Ulta. (WWD Beauty) Valentino Beauty Launches Vendetta Fragrance Franchise. Cosmetics Business reports Valentino Beauty's first prestige fragrance franchise in six years arrives as two scents, not a single flanker. (Cosmetics Business, Global Cosmetics News) Also moving today: Which Beauty Brands and Products Won Prime Week? (WWD Beauty) Luxury Beauty in the Backpack: How Brands Are Attracting Gen Alpha and More (WWD Beauty) Sephora's Global Operations Chief Steps Down After 14 Years - Modaes Global (modaes.com) Jones Road Beauty CEO Cody Plofker is stepping down (Cosmetics Business, Global Cosmetics News, WWD Beauty) Superdrug sales rise 5.2% despite subdued footfall on UK high streets (Cosmetics Business, Global Cosmetics News)
Embed this episode
What this episode covers
WWD's sources say Estée Lauder will hold on to Smashbox, Too Faced and Dr. Jart+, three brands that had quietly been shopped, opting for a turnaround inside the house rather than a sale. Bluemercury names Alex Choueiri, formerly of Kering Beauté and L'Oréal, as chief executive, and Valentino Beauty unveils Vendetta, its first new prestige fragrance franchise in six years, launching as a two-pillar duo. Also today: Prime Day beauty winners spread across skin care, hair and fragrance; prestige brands test lower price points for Gen Alpha and Gen Z; exits at Sephora and Jones Road Beauty; and a 5.2 percent sales rise at Superdrug.
Ready to play
Estée Lauder Keeps Three, Bluemercury's New CEO
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.